financetom
Business
financetom
/
Business
/
Houlihan Lokey Fiscal Q1 Adjusted Earnings, Revenue Increase
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Houlihan Lokey Fiscal Q1 Adjusted Earnings, Revenue Increase
Jul 30, 2024 2:49 PM

05:16 PM EDT, 07/30/2024 (MT Newswires) -- Houlihan Lokey ( HLI ) reported fiscal Q1 adjusted earnings late Tuesday of $1.22 per diluted share, up from $0.89 a year earlier.

Analysts polled by Capital IQ expected $1.20.

Revenue for the quarter ended June 30 was $513.6 million, up from $415.8 million a year earlier.

Analysts surveyed by Capital IQ expected $508.7 million.

The company said its board maintained its quarterly dividend at $0.57 per share, payable Sept. 15 to shareholders of record on Sept. 3.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Highest Performances to Acquire 78% Stake in Singapore White Lingjun
Highest Performances to Acquire 78% Stake in Singapore White Lingjun
Mar 28, 2024
10:33 AM EDT, 03/28/2024 (MT Newswires) -- Highest Performances Holdings ( HPH ) said Thursday it agreed to acquire a nearly 78% stake in Singapore White Lingjun, a subsidiary of Singapore White Group. The wealth management firm said it will issue 20.8 million American depositary shares, which are equivalent to 31.1 million ordinary shares, to White Group. Singapore White Lingjun...
Verizon Communications Joins Global Corporate Renewable Energy Initiative RE100
Verizon Communications Joins Global Corporate Renewable Energy Initiative RE100
Mar 28, 2024
10:32 AM EDT, 03/28/2024 (MT Newswires) -- Verizon Communications ( VZ ) said Thursday it joined RE100, a global corporate renewable energy initiative, to support its goal to source all electricity from renewable sources by 2030, with a midpoint target of 50% by 2025. The company said that as of year-end 2022, Verizon achieved a 23% reduction in scope 1...
Neurocrine Biosciences Starts Phase 1 Trial of Investigational Neuropsychiatric Drug
Neurocrine Biosciences Starts Phase 1 Trial of Investigational Neuropsychiatric Drug
Mar 28, 2024
10:31 AM EDT, 03/28/2024 (MT Newswires) -- Neurocrine Biosciences ( NBIX ) said Thursday that it has started a phase 1 clinical study of NBI-1065890 for the potential treatment of certain neurological and neuropsychiatric conditions. NBI-1065890 is an investigational oral, selective inhibitor of the vesicular monoamine transporter-2, or VMAT2, the company said, adding that these kinds of inhibitors have been...
Omega Therapeutics Cuts Headcount by 35%, Narrows Q4 Loss
Omega Therapeutics Cuts Headcount by 35%, Narrows Q4 Loss
Mar 28, 2024
10:33 AM EDT, 03/28/2024 (MT Newswires) -- Omega Therapeutics ( OMGA ) said Thursday it has cut its headcount by about 35% following a strategic review, extending its cash runway into Q1 of 2025. The clinical-stage drugmaker also reported a net loss of $0.37 per share in Q4, compared with $0.64 loss a year ago. Analysts polled by Capital IQ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved